ArticleTargeted oncology2021
Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC.
Yvette N LambPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleTargeted oncology2021
Yvette N LambPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.